Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.
about
Cell death and autophagy in tuberculosisThe human immunodeficiency virus protease inhibitor ritonavir is potentially active against urological malignancies.Nanoparticle formulation of ormeloxifene for pancreatic cancerDiabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic StudySirolimus and metformin synergistically inhibit hepatocellular carcinoma cell proliferation and improve long-term survival in patients with HCC related to hepatitis B virus induced cirrhosis after liver transplantation.Metformin: A Hopeful Promise in Aging Research.HLA Genotyping using Next Generation Sequencing.Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines.The p53 family orchestrates the regulation of metabolism: physiological regulation and implications for cancer therapy.Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.Pilot study of oral metformin in cancer-bearing cats.Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent.Fertility preservation in Hodgkin's lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era.RNA interference: new mechanistic and biochemical insights with application in oral cancer therapy.Target Fishing by Cross-Docking to Explain Polypharmacological Effects
P2860
Q28387214-505DC3C9-0F5D-428A-8580-3F50CDDAEDFEQ35444159-C4DE4BB7-CB60-490C-A41D-634CB2D3E2F1Q35517037-8895F283-15FC-4EC0-9330-72A96E094DC4Q36712191-E330EE2B-D867-446D-B59F-8F13C897CCDFQ37641827-BF41372A-0F1F-4BD9-B3AD-92106F4493C2Q38756907-5AB6B1D6-C45F-46DD-80B0-D8778283A554Q38879671-8002F027-5A06-4AEA-8869-BD4F2497B7CBQ38973866-B61149D3-3736-4ECE-BD1B-BF01B9D3028EQ39018861-BB81781E-BA70-498D-9D2A-C7B8CF1EA7BCQ47547628-573535DE-D253-48D4-A983-F70A5569528DQ53661861-98973468-461A-494F-ADBF-D78CB4471D72Q55190915-AFD5FE0B-95CE-4320-B8B2-BF4F408CC7FBQ55341751-7500EBA2-F988-4AF1-BF64-261B620AEB5BQ55360697-1821E474-EF31-4340-A381-B85AE4E352CEQ57010613-650C544F-2E89-4BCB-8597-9B7F4FBD2C3E
P2860
Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.
@en
type
label
Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.
@en
prefLabel
Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.
@en
P2093
P2860
P1433
P1476
Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.
@en
P2093
Carmen Crivii
Gabriel Kacso
Ioana Berindan-Neagoe
Lucian Craciun
Mihaela Aldea
P2860
P2888
P304
P356
10.1007/S13277-014-1676-8
P577
2014-02-07T00:00:00Z
P6179
1039237899